← Eichor
Condition: Pneumococcal Vaccine Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pneumococcal Vaccine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT07242092Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
Phase 3 · 1 location(s) · Sinovac Life Sciences Co., Ltd. · NCT06617715Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Serum Collection Study for Assay Development
Phase 1 · 1 location(s) · GPN Vaccines · NCT07205289A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infant
Phase 3 · 3 location(s) · CanSino Biologics Inc. · NCT07017777Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
Phase 4 · 2 location(s) · University of Oxford · NCT06731374Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults
Phase 4 · 24 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06822907Nasopharyngeal Carriage of S. Pneumoniae
NA · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04460313Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
Phase 2 · 1 location(s) · University of California, Davis · NCT02232191National Bacterial Meningitis Study in Children and Newborns
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04664569Safety and Efficacy of wSp Vaccine in Young Children
Phase 2 · 7 location(s) · Serum Life Science Europe GmbH · NCT07216430Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20)
Phase 4 · 7 location(s) · Poitiers University Hospital · NCT04460235Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT07135453A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Phase 1 · 14 location(s) · Merck Sharp & Dohme LLC · NCT07300267Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adoles
Phase 3 · 44 location(s) · Pfizer · NCT07660198Clinical Trial of PCV24 in Infants Aged 2-23 Months
Phase 1 · 2 location(s) · Sinovac Life Sciences Co., Ltd. · NCT06800261A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
Phase N/A · 1 location(s) · Pfizer · NCT06760208A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · 97 location(s) · Pfizer · NCT07629440Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years
Phase 2 · 3 location(s) · Sinovac Life Sciences Co., Ltd. · NCT07300644National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04664556Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemor
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06181656A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healt
Phase 3 · 1 location(s) · Aimei Vacin BioPharm (Zhejiang) Co., Ltd. · NCT06044077Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Phase 2 · 1 location(s) · Seema Bhat · NCT05417165Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition Af
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT03942328Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Phase 3 · 19 location(s) · Sanofi · NCT07348692A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13
Phase 3 · 3 location(s) · Beijing Minhai Biotechnology Co., Ltd · NCT06608199Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT07252791The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
Phase 4 · 1 location(s) · State University of New York at Buffalo · NCT06128915A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
Phase 3 · 21 location(s) · Pfizer · NCT07573462A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Phase N/A · 54 location(s) · Pfizer · NCT05452941
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.